Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017:2017:8102589.
doi: 10.1155/2017/8102589. Epub 2017 Oct 16.

Exclusive Enteral Nutrition Induces Remission in Pediatric Crohn's Disease via Modulation of the Gut Microbiota

Affiliations
Review

Exclusive Enteral Nutrition Induces Remission in Pediatric Crohn's Disease via Modulation of the Gut Microbiota

Dawei Gong et al. Biomed Res Int. 2017.

Abstract

Exclusive enteral nutrition (EEN) has been proven to be effective and safe in treating pediatric Crohn's disease (CD). EEN induces pediatric CD remission possibly through three pathways: (1) direct anti-inflammatory effects, (2) improved epithelial barrier function, and (3) modulation of the gut microbiota. Recent studies have demonstrated that modulation of the gut microbiota plays a major role in EEN-induced remission. Variations of microbial components, which directly influence the diversity and metabolic functions of the gut microbiota, are closely associated with the immunological conditions of the gut and the susceptibility to diseases. The reduction of proinflammatory microbial components and harmful microbial metabolites after EEN treatment greatly decreases the inflammatory injuries of the gut.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Otley A. R., Russell R. K., Day A. S. Nutritional therapy for the treatment of pediatric Crohn's disease. Expert Review of Clinical Immunology. 2010;6(4):667–676. doi: 10.1586/eci.10.37. - DOI - PubMed
    1. Borrelli O., Cordischi L., Cirulli M., et al. Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn’s disease: a randomized controlled open-label trial. Clinical Gastroenterology and Hepatology. 2006;4(6):744–753. doi: 10.1016/j.cgh.2006.03.010. - DOI - PubMed
    1. Levine A., Turner D., Gik T. P., et al. Comparison of outcomes parameters for induction of remission in new onset pediatric Crohn's disease: Evaluation of the porto IBD group “growth relapse and outcomes with therapy” (GROWTH CD) study. Inflammatory Bowel Diseases. 2014;20(2):278–285. doi: 10.1097/01.MIB.0000437735.11953.68. - DOI - PubMed
    1. Grover Z., Muir R., Lewindon P. Exclusive enteral nutrition induces early clinical, mucosal and transmural remission in paediatric Crohn's disease. Journal of Gastroenterology. 2014;49(4):638–645. doi: 10.1007/s00535-013-0815-0. - DOI - PubMed
    1. Ruemmele F. M., Veres G., Kolho K. L., et al. Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease. Journal of Crohn's and Colitis. 2014;8(10):1179–1207. doi: 10.1016/j.crohns.2014.04.005. - DOI - PubMed

Supplementary concepts

LinkOut - more resources